Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Prepaid Assets (2016 - 2025)

Rocket Pharmaceuticals' Prepaid Assets history spans 10 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 34.92% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $3.8 million, down 34.92%, while the annual FY2025 figure was $3.8 million, 34.92% down from the prior year.
  • Prepaid Assets for Q4 2025 was $3.8 million at Rocket Pharmaceuticals, down from $4.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $14.8 million in Q1 2024 and bottomed at $3.3 million in Q4 2021.
  • The 5-year median for Prepaid Assets is $5.6 million (2021), against an average of $6.4 million.
  • The largest annual shift saw Prepaid Assets skyrocketed 176.12% in 2024 before it tumbled 59.27% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $3.3 million in 2021, then soared by 130.97% to $7.7 million in 2022, then tumbled by 34.16% to $5.0 million in 2023, then rose by 15.85% to $5.8 million in 2024, then crashed by 34.92% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for RCKT's Prepaid Assets are $3.8 million (Q4 2025), $4.9 million (Q3 2025), and $5.7 million (Q2 2025).